AzTrials
AzTrials

Pelvic Floor Dysfunction; Vaginal Laxity; Bladder Neck Descent in Parous WomenVLBNDUSNCT07491224

Evaluation of Vaginal Laxity and Bladder Neck Descent in Parous Women Using 2D and 3D Transperineal Ultrasound

An observational study of Pelvic Floor Dysfunction; Vaginal Laxity; Bladder Neck Descent in Parous Women, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

This study aims to evaluate vaginal laxity and bladder neck descent in women who have given birth, using non-invasive 2D and 3D transperineal ultrasound. Participants will complete a short questionnaire about pelvic floor symptoms and undergo a pelvic examination. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
How many people
185 participants
Where
No sites listed yet
Study dates
1 Apr 2026to 1 Apr 2027
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population consists of parous women attending the Women's Health Hospital, Urogynecology and Advanced Ultrasound units. Participants will include women with at least one vaginal delivery or only cesarean deliveries, aged 18 years or older. They will be recruited to assess pelvic floor function and anatomical changes using 2D and 3D transperineal ultrasound.

Who may be able to join

  • Parous women aged 18 years or older
  • Willing to provide informed consent
  • Able to complete the Pelvic Floor Distress Inventory-20 questionnaire
  • Undergo 2D and 3D transperineal ultrasound and POP-Q examination

Who cannot join

  • Pregnant women
  • History of previous prolapse surgery
  • Patients with neurological disorders affecting pelvic floor function

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Ola Abd El Hares Mahros Ali resistant Obstetrics & Gynecology Department Assiut University contact

01158002972

drola6181@gmail.com

About this study

This study aims to evaluate vaginal laxity and bladder neck descent in women who have given birth, using non-invasive 2D and 3D transperineal ultrasound. Participants will complete a short questionnaire about pelvic floor symptoms and undergo a pelvic examination. The ultrasound will measure bladder neck position, levator hiatus dimensions, and related pelvic floor structures at rest and during straining. The study will compare findings between women with previous vaginal deliveries and those who had cesarean sections. Participation is voluntary, and all procedures are safe, non-invasive, and similar to routine clinical practice. The results will help better understand pelvic floor changes after childbirth and may improve the management of pelvic floor disorders.

Read the detailed description

Pelvic floor dysfunction is a common condition affecting women after childbirth, often resulting in vaginal laxity, bladder neck descent, and related pelvic floor symptoms such as urinary incontinence and sexual dysfunction. This observational cross-sectional study will assess 185 parous women, aged 18 years or older, using both 2D and 3D transperineal ultrasound. Participants will complete the Pelvic Floor Distress Inventory-20 questionnaire and undergo a pelvic examination using the POP-Q system after bladder emptying. Ultrasound measurements will include bladder neck height, retrovesical angle, levator hiatal dimensions, levator ani muscle integrity, and other related parameters at rest and during Valsalva maneuver. Women will be categorized based on mode of delivery (vaginal vs cesarean) and results will be analyzed to determine correlations between pelvic floor anatomy and symptom severity. The study aims to provide a comprehensive understanding of pelvic floor alterations in parous women, which may inform clinical assessment and management strategies for pelvic floor dysfunction.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07491224
Study groupRoleWhat they receive
Vaginal Delivery (VD)Women who have had at least one vaginal delivery. Participants will undergo pelvic floor evaluation including 2D and 3D transperineal ultrasound, complete the Pelvic Floor Distress Inventory-20 questionnaire, and undergo POP-Q clinical examination. No therapeutic interventions are assigned.
Cesarean Section (CS)Women who have had only cesarean deliveries. Participants will undergo pelvic floor evaluation including 2D and 3D transperineal ultrasound, complete the Pelvic Floor Distress Inventory-20 questionnaire, and undergo POP-Q clinical examination. No therapeutic interventions are assigned.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Levator Hiatal Area

    Levator hiatal area will be measured using 2D and 3D transperineal ultrasound in the midsagittal plane. Measurements will be taken at rest and during maximal Valsalva maneuver to assess pelvic floor anatomy in parous women and compare between vaginal delivery and cesarean section groups.

    Measured: Measured once during ultrasound assessment after bladder emptying

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2026
  2. Study start1 Apr 2026 (estimated)
  3. Primary completion1 Apr 2027 (estimated)
  4. Study completion1 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
185 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07491224
Sponsor's protocol ID
VaginalLaxity_US_2026
Acronym
VLBNDUS
Status last verified
Mar 2026
First submitted
19 Mar 2026
Last updated
24 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in